Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

被引:0
|
作者
Jaber, S.
Paugam, C.
Futier, E.
机构
来源
LANCET | 2018年 / 392卷 / 10163期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2440 / 2440
页数:1
相关论文
共 50 条
  • [1] Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
    Jaber, Samir
    Paugam, Catherine
    Futier, Emmanuel
    Lefrant, Jean-Yves
    Lasocki, Sigismond
    Lescot, Thomas
    Pottecher, Julien
    Demoule, Alexandre
    Ferrandiere, Martine
    Asehnoune, Karim
    Dellamonica, Jean
    Velly, Lionel
    Abback, Paer-Selim
    de Long, Audrey
    Brunot, Vincent
    Belafia, Fouad
    Roquilly, Antoine
    Chanques, Gerald
    Muller, Laurent
    Constantin, Jean-Michel
    Bertet, Helena
    Klouche, Kada
    Molinari, Nicolas
    Jung, Boris
    [J]. LANCET, 2018, 392 (10141): : 31 - 40
  • [2] Sodium bicarbonate for severe metabolic acidaemia (vol 392, pg 3, 2018)
    Kraut, J. A.
    Madias, N. E.
    [J]. LANCET, 2018, 392 (10157): : 1518 - 1518
  • [3] Early Lactate-Guided Therapy in Intensive Care Unit Patients A Multicenter, Open-Label, Randomized Controlled Trial
    Jansen, Tim C.
    van Bommel, Jasper
    Schoonderbeek, F. Jeanette
    Visser, Steven J. Sleeswijk
    van der Klooster, Johan M.
    Lima, Alex P.
    Willemsen, Sten P.
    Bakker, Jan
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (06) : 752 - 761
  • [4] Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial (vol 6, pg 292, 2021)
    Adamson, D.
    Byrne, A.
    Porter, C.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (04): : E3 - E3
  • [5] Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial
    Adenis, Antoine
    Da Silva, Arlette
    Ben Abdelghani, Meher
    Bourgeois, Vincent
    Bogart, Emilie
    Turpin, Anthony
    Evin, Adrien
    Proux, Aurelien
    Galais, Marie-Pierre
    Jaraudias, Claire
    Quintin, Julia
    Bouquet, Guillaume
    Samalin, Emmanuelle
    Bremaud, Nathalie
    Javed, Sahir
    Henry, Aline
    Kurtz, Jean-Emmanuel
    Cornuault-Foubert, Delphine
    Vandamme, Helene
    Lucchi, Elisabeth
    Pannier, Diane
    Belletier, Christine
    Paul, Murielle
    Touzet, Licia
    Penel, Nicolas
    Chvetzoff, Gisele
    Le Deley, Marie-Cecile
    [J]. ECLINICALMEDICINE, 2024, 74
  • [6] Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
    Shah, Pallav L.
    Orton, Christopher M.
    Grinsztejn, Beatriz
    Donaldson, Gavin C.
    Ramirez, Brenda Crabtree
    Tonkin, James
    Santos, Breno R.
    Cardoso, Sandra W.
    Ritchie, Andrew, I
    Conway, Francesca
    Riberio, Maria P. D.
    Wiseman, Dexter J.
    Tana, Anand
    Vijayakumar, Bavithra
    Caneja, Cielito
    Leaper, Craig
    Mann, Bobby
    Samson, Anda
    Bhavsar, Pankaj K.
    Boffito, Marta
    Johnson, Mark R.
    Pozniak, Anton
    Pelly, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (05): : 415 - 424
  • [7] Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial
    Tascilar, Koray
    Hagen, Melanie
    Kleyer, Arnd
    Simon, David
    Reiser, Michaela
    Hueber, Axel J.
    Manger, Bernhard
    Englbrecht, Matthias
    Finzel, Stephanie
    Tony, Hans-Peter
    Schuch, Florian
    Kleinert, Stefan
    Wendler, Joerg
    Ronneberger, Monika
    Figueiredo, Camille P.
    Cobra, Jayme F.
    Feuchtenberger, Martin
    Fleck, Martin
    Manger, Karin
    Ochs, Wolfgang
    Schmitt-Haendle, Matthias
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Alten, Rieke
    Kruger, Klaus
    Henes, Joerg
    Schett, Georg
    Rech, Juergen
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (11): : E767 - E777
  • [8] Effect on neonatal sepsis following immediate kangaroo mother care in a newborn intensive care unit: a post-hoc analysis of a multicentre, open-label, randomised controlled trial
    Arya, Sugandha
    Chhabra, Suhail
    Singhal, Richa
    Kumari, Archana
    Wadhwa, Nitya
    Anand, Pratima
    Naburi, Helga
    Kawaza, Kondwani
    Newton, Sam
    Adejuyigbe, Ebunoluwa
    Westrup, Bjorn
    Bergman, Nils
    Rettedal, Siren
    Linner, Agnes
    Chauhan, Rahul
    Rani, Nisha
    Minckas, Nicole
    Yoshida, Sachiyo
    Rao, Suman
    Chellani, Harish
    [J]. ECLINICALMEDICINE, 2023, 60
  • [9] Restrictive use of Restraints and Delirium Duration in the Intensive Care Unit (R2D2-ICU): protocol for a French multicentre parallel-group open-label randomised controlled trial
    Sonneville, Romain
    Couffignal, Camille
    Sigaud, Florian
    Godard, Virginie
    Audibert, Juliette
    Contou, Damien
    Celier, Adam
    Djibre, Michel
    Schmidt, Julien
    Jaquet, Pierre
    Dessap, Armand Mekontso
    Bourel, Claire
    Bellot, Romane
    Roy, Carine
    Lamara, Fariza
    Essardy, Fatiha
    Timsit, Jean-Francois
    Cornic, Renaud
    Bouadma, Lila
    [J]. BMJ OPEN, 2024, 14 (04):
  • [10] Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial (vol 391, pg 748, 2018)
    Powles, T.
    Duran, I
    van der Heijden, M.
    [J]. LANCET, 2018, 392 (10156): : 1402 - 1402